These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development. Zhang Z; Zhou L; Liu Q; Zheng Y; Tan X; Huang Z; Guo M; Wang X; Chen X; Liang S; Li W; Song K; Yan K; Li J; Li Q; Zhang Y; Yang S; Cai Z; Dai M; Xian Q; Shi ZL; Xu K; Lan K; Chen Y Emerg Microbes Infect; 2024 Dec; 13(1):2353302. PubMed ID: 38753462 [TBL] [Abstract][Full Text] [Related]
6. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus. Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775 [TBL] [Abstract][Full Text] [Related]
7. ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions. Rawle DJ; Le TT; Dumenil T; Yan K; Tang B; Nguyen W; Watterson D; Modhiran N; Hobson-Peters J; Bishop C; Suhrbier A PLoS Pathog; 2021 Jul; 17(7):e1009723. PubMed ID: 34214142 [TBL] [Abstract][Full Text] [Related]
8. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice. Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A mBio; 2021 Apr; 12(2):. PubMed ID: 33879586 [TBL] [Abstract][Full Text] [Related]
10. Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection. Han K; Blair RV; Iwanaga N; Liu F; Russell-Lodrigue KE; Qin Z; Midkiff CC; Golden NA; Doyle-Meyers LA; Kabir ME; Chandler KE; Cutrera KL; Ren M; Monjure CJ; Lehmicke G; Fischer T; Beddingfield B; Wanek AG; Birnbaum A; Maness NJ; Roy CJ; Datta PK; Rappaport J; Kolls JK; Qin X Am J Respir Cell Mol Biol; 2021 Jan; 64(1):79-88. PubMed ID: 32991819 [TBL] [Abstract][Full Text] [Related]
11. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits. Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK Front Immunol; 2022; 13():1055811. PubMed ID: 36457995 [TBL] [Abstract][Full Text] [Related]
12. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease. Golden JW; Zeng X; Cline CR; Garrison AR; White LE; Fitzpatrick CJ; Kwilas SA; Bowling PA; Fiallos JO; Moore JL; Sifford WB; Ricks KM; Mucker EM; Smith JM; Hooper JW J Gen Virol; 2021 May; 102(5):. PubMed ID: 33961540 [TBL] [Abstract][Full Text] [Related]
13. Characterization of Unique Pathological Features of COVID-Associated Coagulopathy: Studies with AC70 hACE2 Transgenic Mice Highly Permissive to SARS-CoV-2 Infection. Drelich AK; Rayavara K; Hsu J; Saenkham-Huntsinger P; Judy BM; Tat V; Ksiazek TG; Peng BH; Tseng CK PLoS Pathog; 2024 Jun; 20(6):e1011777. PubMed ID: 38913740 [TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice. Ogger PP; Martín MG; Jang S; Zhou J; Brown J; Sukhova K; Furnon W; Patel AH; Cowton V; Palmarini M; Barclay WS; Johansson C Front Immunol; 2024; 15():1383612. PubMed ID: 38742107 [TBL] [Abstract][Full Text] [Related]
15. Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection. Katzman C; Israely T; Melamed S; Politi B; Sittner A; Yahalom-Ronen Y; Weiss S; Abu Rass R; Zamostiano R; Bacharach E; Ehrlich M; Paran N; Nissim L Viruses; 2021 Dec; 14(1):. PubMed ID: 35062215 [TBL] [Abstract][Full Text] [Related]
17. Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2-transgenic mice. Asaka MN; Utsumi D; Kamada H; Nagata S; Nakachi Y; Yamaguchi T; Kawaoka Y; Kuba K; Yasutomi Y JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34463644 [TBL] [Abstract][Full Text] [Related]
18. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19. Li K; Meyerholz DK; Bartlett JA; McCray PB mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553 [TBL] [Abstract][Full Text] [Related]
19. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2. Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750 [TBL] [Abstract][Full Text] [Related]
20. Cutting Edge: Characterization of Low Copy Number Human Angiotensin-Converting Enzyme 2-Transgenic Mice as an Improved Model of SARS-CoV-2 Infection. Bradshaw CM; Georgieva T; Tankersley TN; Taylor-Doyle T; Johnson L; Uhrlaub JL; Besselsen D; Nikolich JŽ J Immunol; 2024 Feb; 212(4):523-528. PubMed ID: 38197714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]